Sign in

Lost your password?
(close)

india

Africa: The Launchpad for Indian Pharma

Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming years, Indian companies have – in the meantime – been rapidly…

Healthcare Politics in 2019

Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. In this article, he gives his predictions for…

Gender Diversity in Indian Pharma

India could boost its GDP by USD 0.7 trillion in 2025 by matching the rate of improvement of gender equality of the…

Indian Contract Research Industry Set for Rapid Growth

The global pharmaceutical outsourcing market was estimated to be USD 115.7 billion in 2016, of which 49 percent is…

Latest Report

In Conversation

Interview: VS Reddy – Founder and Managing Director, British Biologicals, India

VS Reddy, fondly known as ‘The Protein Man of India’ and founder and managing director of British Biologicals, India’s leading nutraceutical company, provides insights into the pioneering role played by British Biologicals in raising awareness about and fostering the use of nutraceuticals in India, while he documents his plans to leverage the company’s unique brands to swiftly strengthen its international…

Interview: Deepak Birewar – Chairman & Founder,…

Thomas Broeer – MD UK and Ireland, Aurobindo

India Pharma Market Facts & Figures Snapshot

India’s pharmaceutical sales and forecast from 2013 up to 2021. Between 2017 and 2021, the Indian pharma…

Related Report

How Beneficial Is The Recent Price Control Exemption For Innovative Drugs In…

Anay Shukla leads the pharmaceutical, life sciences, med-tech and healthcare practice at Nishith Desai Associates,…

Colombia: The Great Indian Investment Wave

With the onset of universal public healthcare, new types of foreign actors have been spying fresh opportunities to…

Indian Pharma Manufacturing: Serving the World

Indian pharma production is growing rapidly – boosted by the Modi government’s ‘Make in India’ campaign…

Indian Biosimilars: Going Global

Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven…

10 Pharma Leaders to Know in India

Indian pharma companies provide affordable generic drugs to patients in almost all countries across the globe,…

Quality Compliance in Indian Pharma: The Learning Curve

One issue grinding the gears of the Indian pharmaceutical industry over recent years has been quality compliance.…

India Healthcare: “Modicare” Lives On

Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…

India: Still a Land of Opportunity for MNCs

For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India…

Meeting US FDA Standards Across the Board in India

In a context where even well-established, multi-billion-dollar domestic companies have received warning letters…

MNCs’ Healthcare Access Initiatives in India

With the Indian public healthcare apparatus straining at the seams to provide affordable access to treatments to…

India’s Drug Regulatory Reforms: Building Trust

Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more…

We use cookies to ensure that we give you the best experience on our site. For more info click here